In Vitro Characterization and Micromechanics of Tumor Cell Chemotactic Protrusion, Locomotion, and Extravasation

AbstractThe objective of this paper is to introduce some novel in vitro applications in characterizing human melanoma cell protrusion and migration in response to soluble extracellular matrix protein stimulation. Specifically, we describe two assay systems: (1) dual-micropipette manipulation and (2) flow-migration chamber. Applications of the dual-micropipet technique provided kinetic measure of cell movement, cyclic pseudopod protrusion, and subsequent cell locomotion governed by chemotactic molecular transport dynamics. Chemotactic concentration gradient was found to influence significantly pseudopod protrusion frequency and locomotion speed, but not the protrusion extension. To further characterize active tumor cell extravasation, a process that involves dynamic tumor cell adhesion to vascular endothelium under flow conditions and subsequent transendothelial migration in response to chemotactic signals from the interstitial space, we developed a flow-migration chemotaxis system. This assay enabled characterization of tumor cell transcellular migration in terms of chemotactic signal gradients, shear forces, and cell-substrate adhesion. Results suggest that shear flow plays significant roles in tumor cell extravasation that is regulated by both tumor cell motility and tumor cell adhesion to endothelial molecules in a cooperative process. © 2002 Biomedical Engineering Society. PAC2002: 8717Jj, 8719Xx

[1]  R. Skalak,et al.  Cytoplasmic rheology of passive neutrophils. , 1991, Biorheology.

[2]  L. Liotta,et al.  Signal transduction for chemotaxis and haptotaxis by matrix molecules in tumor cells , 1990, The Journal of cell biology.

[3]  A. Mastro,et al.  Application of the dual-micropipet technique to the measurement of tumor cell locomotion. , 1999, Experimental cell research.

[4]  C. Dong,et al.  [Ca2+]i as a potential downregulator of α2β1-integrin-mediated A2058 tumor cell migration to type IV collagen , 2001 .

[5]  S Chien,et al.  Locomotion forces generated by a polymorphonuclear leukocyte. , 1992, Biophysical journal.

[6]  I. Macdonald,et al.  Clinical targets for anti-metastasis therapy. , 2000, Advances in cancer research.

[7]  Two phases of pseudopod protrusion in tumor cells revealed by a micropipette. , 1994, Microvascular research.

[8]  S. Zigmond,et al.  ABILITY OF POLYMORPHONUCLEAR LEUKOCYTES TO ORIENT IN GRADIENTS OF CHEMOTACTIC FACTORS , 2003 .

[9]  Larry V. McIntire,et al.  Effect of flow on polymorphonuclear leukocyte/endothelial cell adhesion , 1987 .

[10]  S I Simon,et al.  Neutrophil CD18-dependent arrest on intercellular adhesion molecule 1 (ICAM-1) in shear flow can be activated through L-selectin. , 1997, Journal of immunology.

[11]  T. Stossel.  On the crawling of animal cells. , 1993, Science.

[12]  D. Welch,et al.  Suppression of human melanoma metastasis by introduction of chromosome 6 may be partially due to inhibition of motility, but not to inhibition of invasion. , 1995, Biochemical and biophysical research communications.

[13]  S Neelamegham,et al.  Sequential binding of CD11a/CD18 and CD11b/CD18 defines neutrophil capture and stable adhesion to intercellular adhesion molecule-1. , 2000, Blood.

[14]  D Zicha,et al.  A new direct-viewing chemotaxis chamber. , 1991, Journal of cell science.

[15]  F. Orr,et al.  Intravital videomicroscopic evidence for regulation of metastasis by the hepatic microvasculature: effects of interleukin-1alpha on metastasis and the location of B16F1 melanoma cell arrest. , 1997, Cancer research.

[16]  Properties of red blood cells preserved in SAG-mannitol +/- L-carnitine , 1998 .

[17]  L. Liotta,et al.  Cancer cell invasion and metastasis. , 1992, Scientific American.

[18]  B. Zetter,et al.  Adhesion molecules in tumor metastasis. , 1993, Seminars in cancer biology.